HBV and HCV infection can cause the upregulation of IDO and induce immunosuppression, while hepatitis B and C are closely associated with the development of hepatocellular carcinoma, so it can be further speculated that IDO may increase the risk of HBV and HCV-induced hepatocellular carcinoma [56,57]. This evidence concerns the gene IDO1 and hepatitis B virus infection.